CareRx Corporation (TSX:CRRX)
Canada · Delayed Price · Currency is CAD | Market Cap | 205.63M -8.0% |
| Revenue (ttm) | 376.80M +3.0% |
| Net Income | 26.87M |
| EPS | 0.42 |
| Shares Out | 63.47M |
| PE Ratio | 7.73 |
| Forward PE | 13.09 |
| Dividend | 0.08 (2.47%) |
| Ex-Dividend Date | Sep 15, 2026 |
| Volume | 12,541 |
| Open | 3.230 |
| Previous Close | 3.240 |
| Day's Range | 3.230 - 3.270 |
| 52-Week Range | 3.100 - 4.000 |
| Beta | 0.47 |
| Analysts | Strong Buy |
| Price Target | 5.14 (+58.64%) |
| Est. Earnings | Nov 4, 2026 |
About CareRx
CareRx Corporation, together with its subsidiaries, provides pharmacy services to senior homes and other congregate care settings in Canada. The company also offers medication management services. It serves long-term care homes, retirement homes, assisted living facilities, and group homes. The company was formerly known as Centric Health Corporation and changed its name to CareRx Corporation in June 2020. CareRx Corporation was incorporated in 2001 and is based in Toronto, Canada. [Read more]
Financial Performance
Financial StatementsAnalyst Summary
According to 7 analysts, the average rating for CRRX stock is "Strong Buy." The 12-month stock price target is $5.14, which is an increase of 58.64% from the latest price.
News
CareRx Receives Regulatory Approval for Renewal of its Normal Course Issuer Bid
Toronto, Ontario--(Newsfile Corp. - September 15, 2026) - CareRx Corporation (TSX: CRRX) ("CareRx" or the "Company"), Canada's leading provider of pharmacy services to seniors living and other congreg...
CareRx Slides: Investor presentation
CareRx has posted slides in relation to its latest quarterly earnings report, which was published on September 1, 2026.
CareRx Announces New Credit Agreement with National Bank of Canada
Toronto, Ontario--(Newsfile Corp. - August 27, 2026) - CareRx Corporation (TSX: CRRX) ("CareRx" or the "Company"), Canada's leading provider of pharmacy services to seniors living and other congregate...
CareRx Earnings Call Transcript: Q2 2026
Q2 2026 saw stable revenue and EBITDA, with net income impacted by Ontario ward bed funding changes. A major contract win will add 3,000 retirement beds in Q3, supporting growth targets. Dividend was raised 10%, and margin benefits from generics are expected in 2027.
CareRx Earnings release: Q2 2026
CareRx released its Q2 2026 earnings on July 30, 2026, summarizing the period's financial results.
CareRx Registration statement: Q2 2026
CareRx filed a registration statement on July 30, 2026, providing details about a securities offering with the SEC.
CareRx Registration statement: Q2 2026
CareRx filed a registration statement on July 30, 2026, providing details about a securities offering with the SEC.
CareRx Slides: Q2 2026
CareRx has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on July 30, 2026.
CareRx Corporation to Host Second Quarter 2026 Financial Results Conference Call on Thursday, July 30, 2026 at 8:30 a.m. ET
Toronto, Ontario--(Newsfile Corp. - July 16, 2026) - CareRx Corporation (TSX: CRRX) ("CareRx" or the "Company") today announced it will host a conference call to discuss its second quarter 2026 financ...
CareRx Reports Voting Results from Annual General Meeting of Shareholders
Toronto, Ontario--(Newsfile Corp. - May 28, 2026) - CareRx Corporation (TSX: CRRX) (the "Company"), Canada's leading provider of pharmacy services to seniors living and other congregate care communiti...
CareRx Earnings Call Transcript: Q1 2026
Q1 2026 saw strong revenue and margin growth, driven by new beds and efficiency gains. Ontario's funding stability supports long-term outlook, though removal of ward bed funding may reduce fees by up to CAD 2 million. Generic semaglutide launch expected to benefit margins in 2027.
CareRx Earnings release: Q1 2026
CareRx released its Q1 2026 earnings on May 7, 2026, summarizing the period's financial results.
CareRx Slides: Q1 2026
CareRx has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 7, 2026.
CareRx Registration statement: Q1 2026
CareRx filed a registration statement on May 7, 2026, providing details about a securities offering with the SEC.
CareRx Registration statement: Q1 2026
CareRx filed a registration statement on May 7, 2026, providing details about a securities offering with the SEC.
CareRx Announces Q2 2026 Dividend
Toronto, Ontario--(Newsfile Corp. - May 6, 2026) - CareRx Corporation (TSX: CRRX) ("CareRx" or the "Company"), Canada's leading provider of pharmacy services to seniors living and other congregate car...
CareRx Reports Results for The First Quarter of 2026
Toronto, Ontario--(Newsfile Corp. - May 6, 2026) - CareRx Corporation (TSX: CRRX) ("CareRx" or the "Company"), Canada's leading provider of pharmacy services to seniors living and other congregate car...
CareRx Corporation to Host First Quarter 2026 Financial Results Conference Call on Thursday, May 7, 2026 at 8:30 a.m. ET
Toronto, Ontario--(Newsfile Corp. - April 27, 2026) - CareRx Corporation (TSX: CRRX) ("CareRx" or the "Company") today announced it will host a conference call to discuss its first quarter 2026 financ...
CareRx Welcomes Stability in Long-Term Care Pharmacy Funding in Ontario
Toronto, Ontario--(Newsfile Corp. - April 16, 2026) - CareRx Corporation (TSX: CRRX) ("CareRx" or the "Company"), Canada's leading provider of pharmacy services to seniors living and other congregate ...
CareRx Corporation Announces Participation in the 2026 Bloom Burton & Co. Healthcare Investor Conference
Toronto, Ontario--(Newsfile Corp. - April 15, 2026) - CareRx Corporation (TSX: CRRX) ("CareRx" or the "Company"), Canada's leading provider of pharmacy services to seniors living and other congregate ...
CareRx Slides: Investor presentation
CareRx has posted slides in relation to its latest quarterly earnings report, which was published on March 16, 2026.
CareRx Earnings Call Transcript: Q4 2025
Q4 2025 saw strong revenue and margin growth, with full-year net income positive for the first time. Bed count and operational efficiency improved, leverage declined, and capital returns to shareholders increased. Outlook targets further bed growth and margin expansion.
CareRx Earnings release: Q4 2025
CareRx released its Q4 2025 earnings on March 5, 2026, summarizing the period's financial results.
CareRx Slides: Q4 2025
CareRx has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on March 5, 2026.
CareRx Registration statement: Q4 2025
CareRx filed a registration statement on March 5, 2026, providing details about a securities offering with the SEC.